InMed Pharmaceuticals Inc.
INM | NASDAQ
$13.21
-$4.29 (-24.53%)
At close: Nov 5, 2026, 4:00 PM ET
$12.96
-$0.25 (-1.89%)
After-hours:
Nov 5, 2026, 7:38 PM ET
TTM Period Ending | Q1 2027 Sep 30, 2026 | Q4 2026 Jun 30, 2026 | Q3 2026 Mar 31, 2026 | Q2 2026 Dec 31, 2025 | Q1 2026 Sep 30, 2025 | Q4 2025 Jun 30, 2025 | Q3 2025 Mar 31, 2025 | Q2 2025 Dec 31, 2024 | Q1 2025 Sep 30, 2024 | Q4 2024 Jun 30, 2024 | Q3 2024 Mar 31, 2024 | Q2 2024 Dec 31, 2023 | Q1 2024 Sep 30, 2023 | Q4 2023 Jun 30, 2023 | Q3 2023 Mar 31, 2023 | Q2 2023 Dec 31, 2022 | Q1 2023 Sep 30, 2022 | Q4 2022 Jun 30, 2022 | Q3 2022 Mar 31, 2022 | Q2 2022 Dec 31, 2021 | Q1 2022 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.06B | 2.06B | 4.02M | 5.28M | 5.27M | 5.42M | 4.92M | 4.83M | 4.96M | 4.6M | 6.38M | 6.24M | 5.63M | 5.17M | 2.63M | 1.9M | 1.6M | 1.16M | 644.8K | 335.22K | n/a |
Cost of Revenue | 1.75B | 1.75B | 2.8M | 3.88M | 3.45M | 3.5M | 3.32M | 3.12M | 3.39M | 3.5M | 3.66M | 3.76M | 3.3M | 3.54M | 2.97M | 2.26M | 2M | 873.82K | 464.25K | 194.15K | n/a |
Gross Profit | 306.75M | 307.38M | 1.22M | 1.4M | 1.83M | 1.92M | 1.6M | 1.71M | 1.57M | 1.1M | 2.72M | 2.48M | 2.33M | 1.63M | -345.51K | -355.91K | -392.43K | 285.74K | 180.55K | 141.06K | n/a |
Operating Income | -10.95M | -10.7M | -9.93M | -9.23M | -8.52M | -8.51M | -8.08M | -7.77M | -7.26M | -5.51M | -4.11M | -4.47M | -5.72M | -10.46M | -12.89M | -14.28M | -16.71M | -14.87M | -15.13M | -14.72M | -11.8M |
Interest Income | 165.51K | 244.97K | 295.28K | 264.15K | 192.63K | 155.7K | 245.75K | 393.93K | 584.43K | 711.83K | 766.9K | 812.39K | 746.94K | 662.21K | 508.8K | 337.17K | 215.07K | 122.09K | 84.67K | 50.75K | 22.23K |
Pretax Income | -12.41M | -12.14M | -9.74M | -9.07M | -8.86M | -8.81M | -8.3M | -7.91M | -6.81M | -7.67M | -6.18M | -6.46M | -7.82M | -10.12M | -17.55M | -19.03M | -21.6M | -19.73M | -15.12M | -14.75M | -12.2M |
Net Income | -13.16M | -12.56M | -9.91M | -9.07M | -8.86M | -8.81M | -8.31M | -7.91M | -6.82M | -7.68M | -6.19M | -6.46M | -7.83M | -10.14M | -17.56M | -19.04M | -21.61M | -19.73M | -15.12M | -14.75M | -12.2M |
Selling & General & Admin | 3.68B | 1.88B | 8.42M | 8.01M | 7.48M | 7.37M | 5.52M | 5.56M | 5.37M | 5.25M | 5.9M | 5.85M | 6.47M | 7.33M | 7.11M | 7.62M | 7.96M | 7.17M | 7.08M | 6.59M | 5.49M |
Research & Development | 775.79M | 570.36M | 2.62M | 2.51M | 2.71M | 2.89M | 3.95M | 3.69M | 3.24M | 3.77M | 3.38M | 3.61M | 4.15M | 4.76M | 5.44M | 6.31M | 8.37M | 7.95M | 8.17M | 8.19M | 6.18M |
Other Expenses | -4.45B | -2.44B | 104.91K | 105.51K | 158.71K | 160.09K | 214.85K | 217.32K | 219.35K | -2.4M | -2.46M | -2.51M | -2.57M | n/a | n/a | n/a | n/a | 28.53K | 57.18K | 84.6K | 131.61K |
Operating Expenses | 10.5M | 10.88M | 11.15M | 10.63M | 10.35M | 10.43M | 9.68M | 9.48M | 8.84M | 6.61M | 6.83M | 6.94M | 8.05M | 12.09M | 12.55M | 13.93M | 16.32M | 15.16M | 15.31M | 14.86M | 11.8M |
Interest Expense | 10.7K | 10.7K | 20K | 20K | 371.55K | 371.55K | 351.55K | 351.55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 587.52K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.07M | 12.95M | 13.95M | 14.51M | 13.79M | 13.93M | 13.01M | 12.6M | 12.22M | 10.11M | 10.49M | 10.7M | 11.35M | 15.63M | 15.52M | 16.19M | 18.32M | 16.03M | 15.77M | 15.06M | 11.8M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 7.1K | 7.1K | 7.1K | 7.1K | 2.38K | 3.88K | 7.95K | 17.34K | 14.95K | 13.45K | 9.39K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 5.47M | 4.37M | 4.05M | 3.95M | 3.95M | 2M | 1.1M | 706.55K | 620.13K | 445.95K | 480.65K | 398.67K | 166.41K | 166.41K | 166.41K | 115.03K | 43.28K | 35.79K | 28.3K | 27.69K | 24.1K |
Shares Outstanding (Diluted) | 5.47M | 4.37M | 4.05M | 3.95M | 3.95M | 2M | 1.1M | 706.55K | 620.13K | 445.95K | 480.65K | 398.67K | 166.41K | 166.41K | 166.41K | 115.03K | 43.28K | 35.79K | 28.3K | 27.69K | 24.1K |
EPS (Basic) | -3.30 | -3.48 | -3.27 | -4.48 | -7.41 | -9.51 | -12.64 | -14.28 | -14.35 | -26.88 | -25.22 | -33.65 | -54.67 | -151.45 | -368.64 | -479.43 | -650.26 | -661.57 | -644.08 | -726.70 | -766.33 |
EPS (Diluted) | -3.30 | -3.48 | -3.27 | -4.48 | -7.41 | -9.51 | -12.64 | -14.28 | -14.35 | -26.88 | -25.22 | -33.65 | -54.67 | -151.45 | -368.64 | -479.43 | -650.26 | -661.57 | -644.08 | -726.70 | -766.33 |
EBITDA | -10.02M | -9.8M | -9.23M | -8.56M | -8.03M | -8M | -7.4M | -6.98M | -6.21M | -7.15M | -5.91M | -6.19M | -7.74M | -9.92M | -17.11M | -18.59M | -21.03M | -19.29M | -14.78M | -14.5M | -11.46M |
EBIT | -10.8M | -10.51M | -9.81M | -9.14M | -8.58M | -8.53M | -7.95M | -7.55M | -6.81M | -7.76M | -6.51M | -6.78M | -8.33M | -10.51M | -17.7M | -19.18M | -21.6M | -19.77M | -15.16M | -14.78M | -11.74M |
Depreciation & Amortization | 772.71K | 708.36K | 579.24K | 575.37K | 546.43K | 534.73K | 555.5K | 576.61K | 600.13K | 604.52K | 603.63K | 595.57K | 590.32K | 589.46K | 583.01K | 583.18K | 573.88K | 479.81K | 374.6K | 286.78K | 276.81K |
Add to Watchlist
Select watchlists to add or remove INM